Antifungal efficacy of lasers against dermatophytes and yeasts in vitro

International Journal of Hyperthermia

Volumn 29, Issue 6, 2013, Pages 544-550

  Paasch, Uwe ^a   Mock, Andrea ^a   Grunewald, Sonja ^a   Bodendorf, Marc O ^b   Kendler, Michael ^a   Seitz, Anna Theresa ^a   Simon, Jan C ^a   Nenoff, Pietro ^c  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b Practice for Dermatology and Pathology Dres Reusch and Mielke   (Germany)

^c Haut und Laborarzt Allergologie Andrologie Labor für Medizinische Mikrobiologie Partnerschaft Prof Dr Med Pietro Nenoff and Dr Med Constanze Krüger   (Germany)

Author keywords

Dermatology; Dermatophytes; Fungi; Laser; Nails; Skin; Yeasts

Indexed keywords

AGAR;

ANIMAL TISSUE; ARTHRODERMA GYPSEUM; ARTICLE; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DERMATOPHYTE; FUNGUS CULTURE; FUNGUS GROWTH; GROWTH INHIBITION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IRRADIATION; NEODYMIUM YAG LASER; NONHUMAN; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; YEAST;

CANDIDA; CULTURE MEDIA; HOT TEMPERATURE; HUMANS; LASER THERAPY; MICROSPORUM; NAILS; ONYCHOMYCOSIS; TRICHOPHYTON;

EID: 84882801559     PISSN: 02656736     EISSN: 14645157     Source Type: Journal    
DOI: 10.3109/02656736.2013.823672     Document Type: Article

References (36)

1. Ameen M. Epidemiology of superficial fungal infections. Clin Dermatol 2010;28:197-201
2. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008;51:S2-15
3. Hamnerius N, Berglund J, Faergemann J. Pedal dermatophyte infection in psoriasis. Br J Dermatol 2004;150:1125-1128 (Pubitemid 38932281)
4. Amichai B, Davidovici B, Trau H, Lyakhovitsky A, Grunwald MH, Shemer A. A rationale for systemic treatment in onychomycosis with negative results on fungal examination. Clin Exp Dermatol 2011;36:724-727
5. Scher RK, Tavakkol A, Sigurgeirsson B, Hay RJ, Joseph WS, Tosti A, et al. Onychomycosis: Diagnosis and definition of cure. J Am Acad Dermatol 2007;56:939-944 (Pubitemid 46729696)
6. Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Onychomykose -ein Update: Teil 1 -Prävalenz, Epidemiologie, disponierende Faktoren und Differenzialdiagnose. [Fungal nail infections -an update: Part 1 -Prevalence, epidemiology, predisposing conditions, and differential diagnosis]. Hautarzt 2012;63:30-38
7. Gupta AK, Jain HC, Lynde CW, Macdonald P, Cooper EA, Summerbell RC. Prevalence and epidemiology of onychomycosis in patients visiting physicians' offices: A multicenter Canadian survey of 15 000 patients. J Am Acad Dermatol 2000;43:244-248 (Pubitemid 30626001)
8. Elewski BE. Onychomycosis. Treatment, quality of life, and economic issues. Am J Clin Dermatol 2000;1:19-26
9. Elewski BE. Onychomycosis: Pathogenesis, diagnosis, and management. Clin Microbiol Rev 1998;11:415-429 (Pubitemid 28379092)
10. Elewski BE, Leyden J, Rinaldi MG, Atillasoy E. Office practicebased confirmation of onychomycosis: A US nationwide prospective survey. Arch Intern Med 2002;162:2133-2138 (Pubitemid 35168222)
11. Nenoff P, Ginter-Hanselmayer G, Tietz HJ. Onychomykose -ein Update: Teil 2 -Vom Erreger zur Diagnose -konventionelle und molekularbiologische mykologische Diagnostik. [Fungal nail infections -An update: Part 2: From the causative agent to diagnosis -Conventional and molecular procedures]. Hautarzt 2012;63: 130-138
12. Finch JJ, Warshaw EM. Toenail onychomycosis: Current and future treatment options. Dermatol Ther 2007;20:31-46 (Pubitemid 46568375)
13. Epstein E. How often does oral treatment of toenail onychomycosis produce a disease-free nail? An analysis of published data. Arch Dermatol 1998;134:1551-1554 (Pubitemid 29009255)
14. Gupta AK, Ryder JE, Johnson AM. Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis. Br J Dermatol 2004;150:537-544 (Pubitemid 38446311)
15. Van Duyn GL, Elewski BE. Recent updates in oral terbinafine: Its use in onychomycosis and tinea capitis in the US. Mycoses 2011; 54:e679-e685
16. Tosti A, Piraccini BM, Stinchi C, Colombo MD. Relapses of onychomycosis after successful treatment with systemic antifungals: A three-year follow-up. Dermatology 1998;197: 162-166 (Pubitemid 28395845)
17. Tchernev G, Penev PK, Nenoff P, Zisova LG, Cardoso JC, Taneva T, et al. Onychomycosis: Modern diagnostic and treatment approaches. Wien Med Wochenschr 2013;163:1-12
18. Singal A, Khanna D. Onychomycosis: Diagnosis and management. Indian J Dermatol Venereol Leprol 2011;77:659-672
19. Grover C, Bansal S, Nanda S, Reddy BS, Kumar V. Combination of surgical avulsion and topical therapy for single nail onychomycosis: A randomized controlled trial. Br J Dermatol 2007;157:364-368 (Pubitemid 47083855)
20. Silva JL, Doimo G, Faria DP. The use of high frequency waves to treat onychomycosis: Preliminary communication of three cases. An Bras Dermatol 2011;86:598-600
21. Aspiroz C, Fortuno CB, Rezusta A, Paz-Cristobal P, Dominguez-Luzon F, Gene DJ, et al. Terapia fotodinámica aplicada al tratamiento de las onicomicosis. Presentación de un caso y revisión de la literatura. [Photodynamic therapy for onychomycosis. Case report and review of the literature]. Rev Iberoam Micol 2011;28: 191-193
22. Kamp H, Tietz HJ, Lutz M, Piazena H, Sowyrda P, Lademann J, et al. Antifungal effect of 5-aminolevulinic acid PDT in Trichophyton rubrum. Mycoses 2005;48:101-107 (Pubitemid 40395477)
23. Rothermel E, Apfelberg DB. Carbon dioxide laser use for certain diseases of the toenails. Clin Podiatr Med Surg 1987;4:809-821 (Pubitemid 17167186)
24. Kaplan I, Labandter H. Onychogryphosis treated with the CO2 surgical laser. Br J Plast Surg 1976;29:102-103
25. Apfelberg DB, Rothermel E, Widtfeldt A, Maser MR, Lash H. Preliminary report on use of carbon dioxide laser in podiatry. J Am Podiatry Assoc 1984;74:509-513
26. Vural E, Winfield HL, Shingleton AW, Horn TD, Shafirstein G. The effects of laser irradiation on Trichophyton rubrum growth. Lasers Med Sci 2008;23:349-353
27. Kimura U, Takeuchi K, Kinoshita A, Takamori K, Hiruma M, Suga Y. Treating onychomycoses of the toenail: Clinical efficacy of the sub-millisecond 1064 nm Nd: YAG laser using a 5mm spot diameter. J Drugs Dermatol 2012;11:496-504
28. Hiruma M, Kawada A, Noguchi H, Ishibashi A, Conti Diaz IA. Hyperthermic treatment of sporotrichosis: Experimental use of infrared and far infrared rays. Mycoses 1992;35:293-299 (Pubitemid 23093739)
29. Bornstein E, Hermans W, Gridley S, Manni J. Near-infrared photoinactivation of bacteria and fungi at physiologic temperatures. Photochem Photobiol 2009;85:1364-1374
30. Landsman AS, Robbins AH, Angelini PF, Wu CC, Cook J, Oster M, et al. Treatment of mild, moderate, and severe onychomycosis using 870-and 930-nm light exposure. J Am Podiatr Med Assoc 2010;100:166-177
31. Manevitch Z, Lev D, Hochberg M, Palhan M, Lewis A, Enk CD. Direct antifungal effect of femtosecond laser on Trichophyton rubrum onychomycosis. Photochem Photobiol 2010;86:476-479
32. Hochman LG. Laser treatment of onychomycosis using a novel 0.65-millisecond pulsed Nd:YAG 1064-nm laser. J Cosmet Laser Ther 2011;13:2-5
33. Kozarev J, Vizintin Z. Novel laser therapy in treatment of onychomycosis. J Laser Health Acad 2010;1:1-8
34. Hees H, Raulin C, Baumler W. Laser treatment of onychomycosis: An in vitro pilot study. J Dtsch Dermatol Ges 2012;10:913-918
35. Tietz HJ, Nenoff P. Die Onychomykose -ein Kronjuwel der Dermatologie. [Onychomycosis: A crown jewel of dermatology]. Hautarzt 2012;63:842-847
36. Kozarev J. ClearSteps -Laser onychomycosis treatment: Assessment of efficacy 12 months after treatment and beyond. J Laser Health Acad 2012;2011:S07.